• Corpus ID: 238259077

DRP-VEM: Drug repositioning prediction using voting ensemble

  title={DRP-VEM: Drug repositioning prediction using voting ensemble},
  author={Zahra Ghorbanali and Fatemeh Zare-Mirakabad and Bahram Mohammadpour},
Traditional drug discovery methods are costly and time-consuming. Drug repositioning (DR) is a common strategy to overcome these issues. Recently, machine learning methods have been used extensively in DR problem. The performance of these methods depends on the features, representations and training dataset. In this problem, feature sets include many redundant features, which have a negative effect on the performance of methods. Moreover, selecting an appropriate training set is influential in… 
1 Citations

Figures and Tables from this paper

Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions
This paper introduces a new, completely automated computational drug repurposing pipeline based on drug–gene interaction data, and applies the pipeline to the latest DrugBank drug–Greece interaction data to generate a comprehensive drugRepurposing hint list.


The assessment of efficient representation of drug features using deep learning for drug repositioning
A non-linear method for drug repositioning with large numbers of drug features that predicts new indications for existing drugs systematically, in a more cost-effective way and shorter timeline.
Realizing drug repositioning by adapting a recommendation system to handle the process
This study contributes to the ongoing research efforts by combining multiple features, namely chemical structures, protein interactions and side-effects to predict new indications of target drugs by combining Pareto dominance and collaborative filtering.
deepDR: a network-based deep learning approach to in silico drug repositioning
A network-based deep-learning approach for in silico drug repurposing by integrating 10 networks, termed deepDR, which learns high-level features of drugs from the heterogeneous networks by a multimodal deep autoencoder and infer candidates for approved drugs for which they were not originally approved.
A standard database for drug repositioning
This work provides a gold standard database, repoDB, that consists of both true positives (approved drugs), and true negatives (failed drugs) and makes the full database and all code used to prepare it publicly available.
In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
This study provides a strategy for the fusion of different drug features for in silico drug repositioning and suggests that the 3 drug features used in this manuscript are valuable information for drugRepositioning.
Drug repositioning through integration of prior knowledge and projections of drugs and diseases
This work presents a method based on non-negative matrix factorization, DisDrugPred, to predict the drug-related candidate disease indications and achieves superior prediction performance than several state-of-the-art methods for drug-disease association prediction.
Exploiting drug-disease relationships for computational drug repositioning
In this review, it is shown that computational methods for drug repositioning can be classified in two axes: drug based, where discovery initiates from the chemical perspective, or disease based,where discovery begins from the clinical perspective of disease or its pathology.
Computational Drug Repositioning with Random Walk on a Heterogeneous Network
This study proposes an efficient approach, Random Walk on a Heterogeneous Network for Drug Repositioning (RWHNDR), to prioritize candidate drugs for diseases based on multi-source data, which can achieve better performance compared with other state-of-the-art approaches.
DrugBank: a comprehensive resource for in silico drug discovery and exploration
DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug data with comprehensive drug target information and is fully searchable supporting extensive text, sequence, chemical structure and relational query searches.
Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
A drug treatment–based view of diseases was systematically evaluated and suggested novel drug uses generated using a “guilt by association” approach, which were significantly enriched with respect to previous and ongoing clinical trials.